AI-Designed Drug Reverses Aging Markers: Insilico’s Rentosertib Signals a New Era for Biotech

‼️ 🧠 🧬 Insilico Medicine said its AI-designed lung-disease drug, rentosertib, showed potential to reverse biological aging markers in a mid-stage trial, improving results across six aging clocks that measure chemical changes in the body.

Leave a comment